Position in BNTX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$4,115,766
-$644,900 QoQ
Shares Held
46,307
-7.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swedbank AB holds $1,230,784,492 across 20 Biotechnology names. BNTX ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
11,586,693 | $555,813,663 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
992,108 | $187,558,017 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
215,590 | $166,573,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
271,553 | $121,259,276 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
792,187 | $44,750,643 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $36,103,858 | |
| 7 | INCY |
Incyte Corp
|
362,456 | $34,114,358 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62,215 | $20,585,076 |
All Filings in BNTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,115,766 | 46,307 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $4,760,666 | 50,007 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,921,138 | 49,900 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $4,248,153 | 39,900 | Shares | Defined | 2025-07-10 | |
| No filing history on record for this holder in this stock. | ||||||